Pharmaceutical growth capital
Minority and majority growth investments in specialty pharma, CDMOs and consumer health companies that already have commercial traction and need capital to scale manufacturing, registrations and international distribution.
- Capacity expansion and GMP upgrades
- Portfolio in-licensing and market access
- European and international roll-out